Let me ask you Madg, can Sintx and/or Zimmer include the testing data in the following two links in a submission to the FDA to receive clearance to commercialize a product together one day? Just to clarify, im not saying the data in this testing is enough for clearance. Im just asking could this testing data be part of a submission to the FDA of a product or products containing IP from both companies? If the answer is Yes, then Zimmer is a stakeholder.
Amedica and Zimmer-Biomet (Tokyo Office) provided the femoral heads and acetabular liners; however, neither company actively sponsored the research.
Zimmer Biomet became a stakeholder the moment it allowed its IP to be tested with Sintx IP. It became in interested party in the test results. Thats what makes them a stakeholder! I could, and have, argued that they have been a stakeholder since Sintx founding, (when you factor Centerpulse has been since Sintx began and Zimmer acquired Centerpulse) based on shared personnel, but this is more straightforward.
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.